James Linder, M.D.
Chief Executive Officer, Nebraska Medicine
Jim Linder is the Chief Executive Officer of Nebraska Medicine, the major teaching hospital of the University of Nebraska that provide complex care for all citizens of Nebraska. Previously he was President of the University Technology Development Corporation (UTDC) and Chief Strategist for the University of Nebraska. He most recently served as Interim-President of the University. He is also Professor of Pathology and Microbiology at the University of Nebraska Medical Center. He earned his undergraduate degrees in Biochemistry and Microbiology from Iowa State University, and his Medical Doctor degree from the University of Nebraska Medical Center. After residency training in Pathology at Duke University he returned to the University of Nebraska, where he has been on the faculty full or part-time since 1983. During this time he held many administrative positions, including Vice Chair of Pathology, Director of Surgical Pathology and Cytopathology, Associate Dean for Academic Affairs, Interim Dean of the College of Medicine, President of UNeMed Corporation and Associate Vice Chancellor for Research. He has extensive experience in the commercial sector, serving as a corporate officer and Chief Medical Officer for Cytyc Corporation, Marlborough MA, a leading manufacturer of diagnostic products and surgical devices, from 1995 thru 2007. In 2009 he cofounded Constitution Medical Inc., Boston MA, to develop the Bloodhound™ Integrated Hematology System, this company was acquired by the Roche Group in 2013. He now serves on the Board of Nebraska Medicine, Nobl Health, Streck Diagnostics among others.
He has published over 150 articles, book chapters and instructional materials, five textbooks and holds multiple patents. He is a member of several journal editorial boards and has led several professional organizations. Among his awards are Fellowship in the National Academy of Inventors, Distinguished Teaching Award of the University of Nebraska, the Award for Excellence in Medical Publications from the American Medical Writers Association, and the Israel Davidsohn award for distinguished service to pathology. He and his wife have received awards for supporting entrepreneurship from in the Midwest from Silicon Prairie News and Pipeline Entrepreneurs.
He is married to Karen A. Linder, an author, entrepreneur and CEO of Tethon3D. Together they manage Linseed Capital to fund early-stage companies in the Midwest, and the Linder Foundation, that supports education, entrepreneurship and the arts. Their five children work in business or science.
His academic webpage can be accessed at https://www.unmc.edu/pathology/faculty/bios/linder.html.